Ichnos Glenmark presents data from Phase 1 study of ISB 2001 in multiple myeloma

In a presentation at the 66th American Society of Hematology Annual Meeting, Ichnos Glenmark Innovation (IGI) unveiled promising results from its Phase 1 clinical trial ... Read More